Guggenheim analyst Kelsey Goodwin downgraded MacroGenics (NASDAQ: MGNX) from Buy to Neutral.The analyst comments: "After market close, MGNX provided an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE